Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Drug Combinations × Clear all

NCT07220616 2026-03-18

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Phase 1/2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms